Literature DB >> 9162196

Probes for hidden hyperdiploidy in acute lymphoblastic leukaemia.

A V Moorman1, R Clark, D M Farrell, J M Hawkins, M Martineau, L M Secker-Walker.   

Abstract

The detection of hyperdiploidy (clones with >46 chromosomes) in the bone marrow of patients with acute lymphoblastic leukaemia (ALL) is important because of the prognostic impact of this finding. The high hyperdiploid (HeH) subgroup with 51-68 chromosomes is associated with the best outcome, followed by the low hyperdiploid (HeL) subgroup with 47-50 chromosomes and the triploid/tetraploid (TT) subgroup with >68 chromosomes, which do less well. We present a strategy for the use of fluorescence in situ hybridization (FISH) with chromosome-specific probes to detect hyperdiploidy in interphase cells and to assign cases to a ploidy subgroup. By using a model population of 252 cases, it was seen that ten chromosomes (X, 4, 6, 8, 10, 14, 16, 18, 20, and 21) used in particular combinations and applied in a step-wise manner enabled the detection of 94% of hyperdiploid cases and gave an accurate prediction of ploidy subgroup in 96% of these cases. The detection and classification of each case required the use of four to six probes over two or three steps. Confirmation that this strategy will achieve this level of detection in other hyperdiploid populations was demonstrated by using 250 published karyotypes. This strategy has an application in detecting missing or hidden hyperdiploid cases among cases with failed or normal cytogenetics.

Entities:  

Mesh:

Year:  1996        PMID: 9162196     DOI: 10.1002/(SICI)1098-2264(199605)16:1<40::AID-GCC6>3.0.CO;2-3

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

Review 1.  Demystified ... FISH.

Authors:  J J Waters; A L Barlow; C P Gould
Journal:  Mol Pathol       Date:  1998-04

2.  Backtracking RAS mutations in high hyperdiploid childhood acute lymphoblastic leukemia.

Authors:  Joseph L Wiemels; Michelle Kang; Jeffrey S Chang; Lily Zheng; Carina Kouyoumji; Luoping Zhang; Martyn T Smith; Ghislaine Scelo; Catherine Metayer; Patricia Buffler; John K Wiencke
Journal:  Blood Cells Mol Dis       Date:  2010-08-05       Impact factor: 3.039

Review 3.  Neuroblastoma tumour genetics: clinical and biological aspects.

Authors:  N Bown
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

4.  FLT3 mutation incidence and timing of origin in a population case series of pediatric leukemia.

Authors:  Patrick Chang; Michelle Kang; Anny Xiao; Jeffrey Chang; James Feusner; Patricia Buffler; Joseph Wiemels
Journal:  BMC Cancer       Date:  2010-09-27       Impact factor: 4.430

5.  The United Kingdom Childhood Cancer Study: objectives, materials and methods. UK Childhood Cancer Study Investigators.

Authors: 
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

Review 6.  The Role of Chromosomal Instability in Cancer and Therapeutic Responses.

Authors:  Natalia Vargas-Rondón; Victoria E Villegas; Milena Rondón-Lagos
Journal:  Cancers (Basel)       Date:  2017-12-28       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.